The second volume of the Biomedical translational research
discusses advancements in biomedical research for understanding the
pathophysiology of various diseases towards improving diagnosis and
treatment. It presents the integration of molecular-based
technologies, clinical genomics, and medical informatics to improve
diagnostic and treatment strategies. Further, the book reviews
molecular genomics approaches for diagnosis and managing
tuberculosis. It also covers the innovative strategies for cancer
treatment through targeting metabolic pathways, tumor
microenvironment, cancer stem cells, and immune cells. It
also illuminates novel strategies for heart failure diagnosis and
therapeutic approaches for the treatment of heart failure. It
discusses improvements in translational research for discovery of
new diagnostic tests, identifying novel biomarkers and drugable
targets, and predicting optimal treatments based on understanding
the underlying molecular basis of the disease. Lastly, it reviews
the preclinical models of restenosis and their application and
limitation in the evaluation of device-based interventional
technologies for the treatment of coronary artery diseases.
General
Imprint: |
Springer Verlag, Singapore
|
Country of origin: |
Singapore |
Release date: |
June 2023 |
First published: |
2022 |
Editors: |
R.C. Sobti
• Awtar Krishan Ganju
|
Dimensions: |
235 x 155mm (L x W) |
Pages: |
491 |
Edition: |
1st ed. 2022 |
ISBN-13: |
978-981-16-8847-8 |
Categories: |
Books
|
LSN: |
981-16-8847-8 |
Barcode: |
9789811688478 |
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!